CN108379112A - 用于细纹治疗的真皮填充剂组合物 - Google Patents

用于细纹治疗的真皮填充剂组合物 Download PDF

Info

Publication number
CN108379112A
CN108379112A CN201810249654.6A CN201810249654A CN108379112A CN 108379112 A CN108379112 A CN 108379112A CN 201810249654 A CN201810249654 A CN 201810249654A CN 108379112 A CN108379112 A CN 108379112A
Authority
CN
China
Prior art keywords
composition
gel
skin
months
hydrogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810249654.6A
Other languages
English (en)
Chinese (zh)
Inventor
G·N·恩吉康
俞小杰
刘福田
萨米特·包利华
N·J·马内西斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Industrie SAS
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2012/052125 external-priority patent/WO2013028904A2/en
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of CN108379112A publication Critical patent/CN108379112A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/505—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201810249654.6A 2011-09-14 2012-09-13 用于细纹治疗的真皮填充剂组合物 Pending CN108379112A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161534780P 2011-09-14 2011-09-14
US61/534,780 2011-09-14
PCT/US2012/052125 WO2013028904A2 (en) 2011-08-25 2012-08-23 Dermal filler compositions including antioxidants
USPCT/US2012/052125 2012-08-23
CN201280055657.7A CN104105474B (zh) 2011-09-14 2012-09-13 用于细纹治疗的真皮填充剂组合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201280055657.7A Division CN104105474B (zh) 2011-09-14 2012-09-13 用于细纹治疗的真皮填充剂组合物

Publications (1)

Publication Number Publication Date
CN108379112A true CN108379112A (zh) 2018-08-10

Family

ID=47883970

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201810249654.6A Pending CN108379112A (zh) 2011-09-14 2012-09-13 用于细纹治疗的真皮填充剂组合物
CN201280055657.7A Expired - Fee Related CN104105474B (zh) 2011-09-14 2012-09-13 用于细纹治疗的真皮填充剂组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201280055657.7A Expired - Fee Related CN104105474B (zh) 2011-09-14 2012-09-13 用于细纹治疗的真皮填充剂组合物

Country Status (9)

Country Link
EP (1) EP2755630A2 (enExample)
JP (4) JP6125509B2 (enExample)
KR (4) KR20200116168A (enExample)
CN (2) CN108379112A (enExample)
AU (1) AU2012308503B2 (enExample)
CA (1) CA2848833C (enExample)
HK (1) HK1198124A1 (enExample)
RU (1) RU2626513C2 (enExample)
WO (1) WO2013040242A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110467689A (zh) * 2019-09-09 2019-11-19 山东众山生物科技有限公司 一种透明质酸衍生物及其制备方法
CN111249172A (zh) * 2020-01-15 2020-06-09 陈勇 一种美容注射凝胶及其制备方法

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
EP2484387A1 (en) 2011-02-03 2012-08-08 Q-Med AB Hyaluronic acid composition
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
ES2738208T3 (es) 2011-06-03 2020-01-20 Allergan Ind Sas Composiciones de relleno dérmico que incluyen antioxidantes
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
HK1198124A1 (en) * 2011-09-14 2015-03-13 Sumit Paliwal Dermal filler compositions for fine line treatment
EP4578462A3 (en) * 2011-12-08 2025-12-03 ALLERGAN Industrie, SAS Dermal filler compositions
US20140315828A1 (en) 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
CA2910325A1 (en) * 2013-04-25 2014-10-30 Aluron Biopharma Inc. Crosslinked hyaluronic acid compositions
WO2016128783A1 (en) * 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
PL3256179T3 (pl) 2015-02-13 2020-05-18 Allergan Industrie, Sas Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda
US10988600B2 (en) * 2016-06-23 2021-04-27 Galderma Holding SA Cyclodextrin-grafted cross-linked hyaluronic acid complexed with active drug substances and uses thereof
CA3033536A1 (en) 2016-08-24 2018-03-01 Allergan, Inc. Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
US11389563B2 (en) 2017-06-12 2022-07-19 Advanced Aesthetic Technologies, Inc. Dermal filler
US20230190997A1 (en) 2017-06-26 2023-06-22 Evolved By Nature, Inc. Silk-hyaluronic acid based tissue filers and methods of using the same
IL299584A (en) * 2017-06-26 2023-03-01 Evolved By Nature Inc Tissue fillers based on hyaluronic acid and silk and methods of using them
US20190021957A1 (en) * 2017-07-19 2019-01-24 Dentsply Sirona Inc. Water-soluble hydrogel-based dental composition and methods of making and using same
KR102532037B1 (ko) * 2017-12-29 2023-05-12 마텍스 랩 에스.피.에이 히알루론산 염기를 가지는 필러를 제조하는 방법
KR101967153B1 (ko) 2018-04-04 2019-04-09 윤성준 주름과 피부 결손 및 위축성 흉터 개선을 위한 필러 배합 조성물
JP7374133B2 (ja) * 2018-06-15 2023-11-06 クロマ－ファーマ ゲゼルシャフト エム．ベー．ハー． 安定化されたヒアルロン酸
CA3124196A1 (en) 2018-12-19 2020-06-25 Evolved By Nature, Inc. Silk-hyaluronic acid tissue fillers and methods of making and using the same
IT201900006929A1 (it) * 2019-05-16 2020-11-16 Giuliani Spa Kit per il trattamento estetico della pelle
CN110907370A (zh) * 2019-12-04 2020-03-24 桂林理工大学 一种普适性的超灵敏化学与生物比色传感方法
US20230040919A1 (en) * 2019-12-26 2023-02-09 Allergan, Inc. Crosslinked ha-collagen hydrogels as dermal fillers
EP4448588A1 (en) 2022-01-11 2024-10-23 WiQo S.p.A. New hyaluronic acid derivatives as innovative fillers
WO2024055132A1 (es) * 2022-09-12 2024-03-21 Universidad De Talca Método para la síntesis de un copolímero ramificado de ácido hialurónico y ácido poli(láctico-co-glicólico)
KR102782287B1 (ko) 2022-12-19 2025-03-18 주식회사 코루파마 히알루론산과 아가 또는 아가로오스 복합화 하이드로겔 제조방법, 이로부터 제조된 히알루론산과 아가 또는 아가로오스를 포함하는 하이드로겔 및 이를 포함하는 필러 조성물
EP4450062A1 (en) * 2023-04-20 2024-10-23 Abiogen Pharma S.p.A. Composition for the treatment of osteoarthrosis

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058961A1 (en) * 2000-02-08 2001-08-16 S.F.I.R. S.P.A. Societa' Fondiaria Industriale Romagnola Gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters or mixtures thereof
US20010018464A1 (en) * 2000-01-24 2001-08-30 Kuraray Co., Ltd. Water-swellable polymer gel and process for preparing the same
US20010039336A1 (en) * 1987-09-18 2001-11-08 Miller Robert J. Water insoluble derivatives of polyanionic polysaccharides
WO2004067575A1 (en) * 2003-01-31 2004-08-12 Biosphere S.P.A. Water soluble and biocompatible gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters
US20050281880A1 (en) * 2004-05-20 2005-12-22 Wei Wang Methods for making injectable polymer hydrogels
WO2006021644A1 (fr) * 2004-07-23 2006-03-02 Asius Jerome Acide hyaluronique reticule soluble dans l'eau, son procede de preparation, implant contenant ledit acide hyaluronique reticule, et son utilisation
CN1837265A (zh) * 2006-04-25 2006-09-27 江南大学 一种透明质酸－羧甲基纤维素复合改性的方法
CN1893989A (zh) * 2003-12-22 2007-01-10 安尼卡医疗有限公司 用于组织填充的交联透明质酸
CN1902232A (zh) * 2003-12-30 2007-01-24 建新公司 源自交联的透明质酸和/或hylan的粘性凝胶、其制备和用途
CN1927892A (zh) * 2006-09-07 2007-03-14 重庆大学 赖氨酸－壳聚糖树脂及其制备方法
EP2011816A1 (fr) * 2007-07-05 2009-01-07 Estelle Piron Gel co-réticulé de polysaccharides
CN101432311A (zh) * 2006-02-28 2009-05-13 诺维信生物聚合物公司 透明质酸衍生物
KR20090110090A (ko) * 2008-04-17 2009-10-21 엘지전자 주식회사 초음파를 이용한 인듐 셀레나이드 나노화합물의 제조방법및 이를 포함하는 화합물 반도체 태양전지
CN101594892A (zh) * 2006-12-06 2009-12-02 皮埃尔·法布尔皮肤化妆品公司 真皮内注射用透明质酸水凝胶
CN101611063A (zh) * 2006-11-10 2009-12-23 施泰福实验室股份有限公司 交联透明质酸及其制备方法
CN101918032A (zh) * 2007-12-21 2010-12-15 恩希瑟有限公司 含有活性物质的交联水凝胶
CN101961344A (zh) * 2009-07-23 2011-02-02 山东省生物药物研究院 药物组合物及其应用
WO2011023355A2 (en) * 2009-08-27 2011-03-03 Fidia Farmaceutici S.P.A. Viscoelastic gels as novel fillers
WO2011063394A2 (en) * 2009-11-23 2011-05-26 Olmstead Stephen F Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
AU2003206922A1 (en) 2003-02-19 2004-09-09 Aventis Pharmaceuticals Holdings Inc. Composition and method for intradermal soft tissue augmentation
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
FR2878444B1 (fr) 2004-11-30 2008-04-25 Corneal Ind Soc Par Actions Si Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations
EP1934265A4 (en) * 2005-09-15 2009-06-24 Univ Utah Res Found POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING SAME
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US20110172180A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US20110171311A1 (en) 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
ES2738208T3 (es) * 2011-06-03 2020-01-20 Allergan Ind Sas Composiciones de relleno dérmico que incluyen antioxidantes
HK1198124A1 (en) * 2011-09-14 2015-03-13 Sumit Paliwal Dermal filler compositions for fine line treatment

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010039336A1 (en) * 1987-09-18 2001-11-08 Miller Robert J. Water insoluble derivatives of polyanionic polysaccharides
US20010018464A1 (en) * 2000-01-24 2001-08-30 Kuraray Co., Ltd. Water-swellable polymer gel and process for preparing the same
WO2001058961A1 (en) * 2000-02-08 2001-08-16 S.F.I.R. S.P.A. Societa' Fondiaria Industriale Romagnola Gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters or mixtures thereof
WO2004067575A1 (en) * 2003-01-31 2004-08-12 Biosphere S.P.A. Water soluble and biocompatible gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters
CN1893989A (zh) * 2003-12-22 2007-01-10 安尼卡医疗有限公司 用于组织填充的交联透明质酸
CN1902232A (zh) * 2003-12-30 2007-01-24 建新公司 源自交联的透明质酸和/或hylan的粘性凝胶、其制备和用途
US20050281880A1 (en) * 2004-05-20 2005-12-22 Wei Wang Methods for making injectable polymer hydrogels
FR2873379B1 (fr) * 2004-07-23 2008-05-16 Jerome Asius Procede de preparation d'acide hyaluronique reticule, acide hyaluronique reticule susceptible d'etre obtenu par ledit procede, implant contenant ledit acide hyaluronique reticule, et son utilisation
WO2006021644A1 (fr) * 2004-07-23 2006-03-02 Asius Jerome Acide hyaluronique reticule soluble dans l'eau, son procede de preparation, implant contenant ledit acide hyaluronique reticule, et son utilisation
CN101432311A (zh) * 2006-02-28 2009-05-13 诺维信生物聚合物公司 透明质酸衍生物
CN1837265A (zh) * 2006-04-25 2006-09-27 江南大学 一种透明质酸－羧甲基纤维素复合改性的方法
CN1927892A (zh) * 2006-09-07 2007-03-14 重庆大学 赖氨酸－壳聚糖树脂及其制备方法
CN101611063A (zh) * 2006-11-10 2009-12-23 施泰福实验室股份有限公司 交联透明质酸及其制备方法
CN101594892A (zh) * 2006-12-06 2009-12-02 皮埃尔·法布尔皮肤化妆品公司 真皮内注射用透明质酸水凝胶
EP2011816A1 (fr) * 2007-07-05 2009-01-07 Estelle Piron Gel co-réticulé de polysaccharides
CN101918032A (zh) * 2007-12-21 2010-12-15 恩希瑟有限公司 含有活性物质的交联水凝胶
KR20090110090A (ko) * 2008-04-17 2009-10-21 엘지전자 주식회사 초음파를 이용한 인듐 셀레나이드 나노화합물의 제조방법및 이를 포함하는 화합물 반도체 태양전지
CN101961344A (zh) * 2009-07-23 2011-02-02 山东省生物药物研究院 药物组合物及其应用
WO2011023355A2 (en) * 2009-08-27 2011-03-03 Fidia Farmaceutici S.P.A. Viscoelastic gels as novel fillers
WO2011063394A2 (en) * 2009-11-23 2011-05-26 Olmstead Stephen F Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
D.J.PARK ET AL,: "in vitro evaluation of conjugated hyaluronic acid with ascorbic acid", 《JOURNAL OF BONE&JOINT SURGERY》 *
JUNSEOK YEOM: "Effect of Cross-Linking Reagents for Hyaluronic Acid Hydrogel Dermal Fillers on Tissue Augmentation and Regeneration", 《BIOCONJUGATE CHEM.》 *
X.XUEJUN ET AL.: "Preparation and Characterization of a Hydrogel from Low-Molecular Weight Hyaluronic Acid", 《JOURNAL OF BIOACTIVE ANDCOMPATIBLE POLYMERS》 *
曾戎等: "《生物医用仿生高分子材料》", 31 October 2010, 华南理工大学出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110467689A (zh) * 2019-09-09 2019-11-19 山东众山生物科技有限公司 一种透明质酸衍生物及其制备方法
CN111249172A (zh) * 2020-01-15 2020-06-09 陈勇 一种美容注射凝胶及其制备方法

Also Published As

Publication number Publication date
JP2017140433A (ja) 2017-08-17
HK1198124A1 (en) 2015-03-13
AU2012308503B2 (en) 2015-08-13
CA2848833C (en) 2017-04-04
WO2013040242A2 (en) 2013-03-21
WO2013040242A3 (en) 2014-03-13
AU2012308503A1 (en) 2014-04-03
CA2848833A1 (en) 2013-03-21
JP2014526342A (ja) 2014-10-06
CN104105474A (zh) 2014-10-15
KR102161861B1 (ko) 2020-10-26
KR20140096028A (ko) 2014-08-04
KR20200116168A (ko) 2020-10-08
RU2014113663A (ru) 2015-10-20
JP6125509B2 (ja) 2017-05-10
JP2019058692A (ja) 2019-04-18
EP2755630A2 (en) 2014-07-23
RU2626513C2 (ru) 2017-07-28
JP2021100603A (ja) 2021-07-08
CN104105474B (zh) 2018-04-06
KR20220013588A (ko) 2022-02-04
KR20210125119A (ko) 2021-10-15

Similar Documents

Publication Publication Date Title
CN104105474B (zh) 用于细纹治疗的真皮填充剂组合物
AU2021221920B2 (en) Dermal filler compositions
JP6749993B2 (ja) 抗酸化物質を含む皮膚充填剤組成物
US10994049B2 (en) Dermal filler compositions for fine line treatment
US11083684B2 (en) Dermal filler compositions
US20220023186A1 (en) Dermal filler compositions
AU2015255254B2 (en) Dermal filler compositions for fine line treatment
HK1263337A1 (en) Dermal filler compositions for fine line treatment
HK1238576A (en) Dermal filler compositions
HK1238576A1 (en) Dermal filler compositions

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20190925

Address after: Fa Guo Pulanri

Applicant after: ALLERGAN INDUSTRIE S.A.S.

Address before: California, USA

Applicant before: ALLERGAN, Inc.

TA01 Transfer of patent application right
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1263337

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180810

WD01 Invention patent application deemed withdrawn after publication